The National Cancer Institute (NCI) is pleased to announce the Outstanding Investigator Award (OIA). The OIA will support investigators with outstanding records of productivity in cancer research with up to $600,000 in direct costs per year for seven years to provide funding stability. NCI anticipates making about 50 awards annually. Vanderbilt may submit more than one application to this program, provided each is scientifically distinct.
The OIA will allow funded investigators the freedom to embark on long-term projects of unusual potential in cancer research; the opportunity to take greater risks and be more adventurous in their lines of inquiry; and sufficient time to develop new techniques.
The applicant PD/PI will be expected to commit at least 50 percent of his/her research activities to the OIA. The institution will be expected to commit at least 20 percent salary support.
An institutional letter of nomination is required for applicants to this funding opportunity. Anyone interested in being considered for nomination to this program must submit the following (in PDF format) to firstname.lastname@example.org by 5 p.m. Aug. 8. Please specify “NCI Outstanding Investigator Award (R35)” in the email subject line:
- A brief (two-page maximum) research plan including summary budget;
- A very brief letter of support from the department chair, including a statement regarding effort support; and
- A new pilot version of the NIH Biosketch. The pilot Biosketch includes the addition of a new “Contribution to Science” section. The “Pilot Biographical Sketch Instructions and Sample” can be downloaded here.
The VICC Executive Committee will work in consultation with the associate vice chancellors for research to conduct internal review and selection of nominees. All internal applicants will be notified of internal review decisions before the OIA Letter of Intent due date of Sept. 20.
The OIA application due date is Oct. 20, 2014. For other details, please review the OIA Program Announcement: PAR-14-267. If you have any questions, you may contact Susan Meyn in the Office of Research, or the NCI Program Office:
National Cancer Institute